Contact information
Research groups
Colleges
Pedro Folegatti
MD, DTM&H, MSc
Clinical Research Fellow
Vaccine Clinical Trials
I am a Clinical Research Fellow and DPhil candidate on the Influenza and Emerging Pathogens vaccine clinical development programmes at The Jenner Institute - University of Oxford
My research focuses on the use of the simian adenovirus vector ChAdOx1 as a platform technology for vaccine development against emerging pathogens.
I am an investigator and the lead clinician for the COVID-19, MERS-CoV, Chikungunya, Zika, and Rift Valley Fever vaccine clinical trials
I trained as an Infectious Diseases physician in Brazil and hold a Masters degree in Public Health from the London School of Hygiene and Tropical Medicine.
Recent publications
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Journal article
Clemens SAC. et al, (2021), Nature Communications, 12
-
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T
H
1 response with a diverse TCR repertoire
Journal article
Swanson PA. et al, (2021), Science Translational Medicine, 13
-
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Ratcliff J. et al, (2021)
-
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Journal article
Feng S. et al, (2021), Nature Medicine, 27, 2032 - 2040
-
Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses
Ogbe A. et al, (2021)